OHMX.bio is now a CRO partner for cutting-edge omics services under the Anacura umbrella. It offers on-demand multi-omics research services with a personalized project approach, combining emerging multi-omics technologies with integrated wet lab and high-standard bioinformatics expertise.
I supported the exclusive in-licensing of Epify’s IP, developed with Maastricht University. I then developed the strategy for OHMX.bio’s companion diagnostics department, aligned the marketing communication accordingly and initiated conversations with potential customers.
Katrien worked as BD for our OHMX.bio CDx department and was instrumental in performing a market study around usage of epigenetic CDx biomarkers and working out the in-licensing of Epify's IP portfolio. Streamlining our BD/Sales activities, initiating customer communication, working out project agreements within this new department allowed further growth. Next to her extensive BD/Sales expertise and vast scientific knowledge, Katrien is above all a very pleasant and trustworthy person to work with!
